国际妇产科学杂志 ›› 2019, Vol. 46 ›› Issue (6): 688-692.

• 综述 • 上一篇    下一篇

循环肿瘤DNA在卵巢癌的应用进展

刘毓,刘斌,倾丽梅,刘翠萍,徐丽媛,杨永秀   

  1. 730000 兰州大学第一临床医学院,甘肃省妇科肿瘤重点实验室(刘毓,倾丽梅,刘翠萍,徐丽媛,杨永秀);兰州大学第一医院妇产科(杨永秀);民勤县人民医院药剂科(刘斌)
  • 收稿日期:2019-05-23 修回日期:2019-07-17 出版日期:2019-12-15 发布日期:2019-12-15
  • 通讯作者: 杨永秀,E-mail:yongxiuyang@163.com E-mail:yongxiuyang@163.com;yangyongxiu2018@163.com
  • 基金资助:
     

Progress in the Application of Circulating Tumor DNA Detection in Ovarian Cancer

LIU Yu,LIU Bin,QING Li-mei,LIU Cui-ping,XU Li-yuan,YANG Yong-xiu   

  1. The First Clinical Medical College of Lanzhou University,Key Laboratory of Gynecologic Oncology of Gansu Province,Lanzhou 730000,China(LIU Yu,QING Li-mei,LIU Cui-ping,XU Li-yuan,YANG Yong-xiu);Department of Obstetrics and Gynecology,The First Hospital of Lanzhou University,Lanzhou 730000,China(YANG Yong-xiu);Department of Pharmacy,People′s Hospital of Minqin County,Minqin 733300,Gansu Province,China(LIU Bin)
  • Received:2019-05-23 Revised:2019-07-17 Published:2019-12-15 Online:2019-12-15
  • Contact: YANG Yong-xiu,E-mail:yongxiuyang@163.com E-mail:yongxiuyang@163.com;yangyongxiu2018@163.com
  • Supported by:
     

摘要: 卵巢癌起病隐匿,严重危害妇女健康,其缺乏有效的治疗手段,5年生存率极低,死亡率居妇科恶性肿瘤首位。因此卵巢癌的早期诊断、复发和转移的早期发现具有极其重要的意义,是临床亟待改善并提高的问题,然而既往实体肿瘤的病理检测及影像学检查并不能更好地改变此现状。循环肿瘤DNA(ctDNA)是肿瘤细胞坏死、凋亡后释放的一种循环游离DNA(cfDNA),携带肿瘤基因组的全部表观遗传特征。ctDNA作为液体活检的方法之一,可以实时、动态地了解肿瘤情况。近年来,ctDNA检测在卵巢癌的早期诊断、耐药性监测和疗效评估中发挥越来越重要的作用。现综述ctDNA在卵巢癌临床诊疗中的应用进展,讨论需要解决的问题,并为其在卵巢癌中的应用提供潜在的方向。

关键词: 卵巢肿瘤, DNA, 肿瘤, 血液循环, 基因, 突变

Abstract: Ovarian cancer has insidious onset and seriously endangers women′s health. The 5-year survival rate is extremely low due to lack of effective treatment. The mortality rate ranks first among gynecological malignant tumors. Therefore, the early diagnosis, early detection of recurrence and metastasis about ovarian cancer is of great significance, which is an urgent clinical condition waiting for improvement. However, the previous pathological examination and imaging examination of solid tumors cannot better change this situation. Circulating tumor DNA (ctDNA) is a kind of circulating free DNA (cfDNA) released after tumor cell necrosis and apoptosis, which carries all the epigenetic characteristics of tumor genome. As one of liquid biopsy method, ctDNA detection can reflect the state of tumor constantly and dynamically. In recent years, ctDNA detection has played an increasingly important role in early diagnosis, drug resistance prediction and efficacy evaluation of ovarian cancer. The article reviews application progress of ctDNA in clinical diagnosis and treatment of ovarian cancer, discusses the problems that need to be solved, and provides potential directions for its application in ovarian cancer.

Key words: Ovarian neoplasms, DNA, neoplasm, Blood circulation, Genes, Mutation

中图分类号: